SLADE Compounding has won a major South Australian contract, having been named as the sole supplier of sterile compounded antibiotics, chemotherapy and analgesics for all SA public hospitals.
The expansion of Slade's offering follows almost three years of providing chemotherapy compounding services to the hospitals, with the agreement awarded following a public tender process this year.
CEO David Slade (pictured) said the company welcomed the opportunity to extend its services in SA, with the deal seeing the firm service up to 26 public hospitals across the state.
"This is an acknowledgement of the exceptional service that Slade Health has been providing to hospitals in South Australia.
"We spend a great deal of time ensuring we understand and deliver on South Australian hospital requirements," he said.
Slade's TGA-licensed facilities currently provide services to more than 200 hospitals in all Australian states, in both regional and metropolitan areas.
Slade Health is part of Icon Group, which also encompasses Epic Pharmacy to provide medication management and pharmacy services to the hospital, oncology and aged care sectors.
The above article was sent to subscribers in Pharmacy Daily's issue from 11 Sep 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 11 Sep 19
